Combination of systemic acetazolamide and topical dorzolamide.
Epstein
R
R
Brown
S V
SV
Dennis
R F
RF
Konowal-Allen
A
A
D000086:Acetazolamide / Q000009:adverse effects* / Q000627:therapeutic use; D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D003316:Corneal Diseases / Q000139:chemically induced*; D004359:Drug Therapy, Combination; D004728:Endothelium, Corneal / Q000187:drug effects; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D007429:Intraocular Pressure; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use; D013876:Thiophenes / Q000009:adverse effects* / Q000627:therapeutic use
D002257:Carbonic Anhydrase Inhibitors; D013449:Sulfonamides; D013876:Thiophenes; C062765:dorzolamide; D000086:Acetazolamide